Search Menu
HERU

Charlotte Kennedy

Charlotte Kennedy
Charlotte Kennedy
Charlotte Kennedy

Research Assistant

About

Biography

Charlotte joined the Health Economics Research Unit (HERU) in November 2019 as a Research Assistant under the Assessment of Health Technologies theme. Currently, she is involved in the critical assessment of the economic methods used in single technology assessments as part of the evidence review group within the university. Previous projects include the conceptualisation and development of an economic model for childhood Asthma, health economic analysis alongside the RAACENO clinical trial and conducting a micro-costing analysis for the EDNA study. She graduated from the University of York in January 2020 with a distinction in MSc Health Economics; her MSc thesis investigated time preference as a mediator of the spousal correlation in smoking. This was completed within the unit during the summer of 2019. She also graduated from the University of Birmingham in June 2018 with a BSc Hons in Mathematical Economics and Statistics.

Qualifications

  • BSc Mathematical Economics and Statistics 
    2018 - University of Birmingham 
  • MSc Health Economics 
    2020 - University of York 
Research

Research Areas

Economics

View Research Area
Publications

Page 1 of 1 Results 1 to 10 of 10

  • Early detection of neovascular age-related macular degeneration: an economic evaluation based on data from the EDNA study

    Hernández, R., Banister, K., Goulao, B., Cook, J., Sivaprasad, S., Hogg, R. E., Azuara-Blanco, A., Heimann, H., Dimitrova, M. P., Gale, R., Porteous, M., Ramsay, C., Chakravarthy, U., Scotland, G., Kennedy, C.
    British Journal of Ophthalmology, vol. 106, no. 12, pp. 1754-1761
    Contributions to Journals: Articles

  • Reducing asthma attacks in children using exhaled nitric oxide (RAACENO) as a biomarker to inform treatment strategy: a multicentre, parallel, randomised, controlled, phase 3 trial

    Turner, S., Cotton, S., Wood, J., Bell, V., Raja, E. A., Scott, N., Morgan, H., Lawrie, L., Emele, D., Kennedy, C., Scotland, G., Fielding, S., MacLennan, G., Norrie, J., Forrest, M., Gaillard, E. A., de Jongste, J. C., Pijnenburg, M. W., Thomas, M., Price, D.
    The Lancet. Respiratory medicine, vol. 10, no. 6, pp. 584-592
    Contributions to Journals: Articles

  • Treatment guided by fractional exhaled nitric oxide in addition to standard care in 6- to 15-year-olds with asthma: the RAACENO RCT

    Turner, S., Cotton, S., Wood, J., Bell, V., Raja, E. A., Scott, N., Morgan, H., Lawrie, L., Emele, D., Kennedy, C., Scotland, G., Fielding, S., MacLennan, G., Norrie, J., Forrest, M., Gaillard, E. A., de Jongeste, J., Pijnenburg, M. W., Thomas, M., Price, D.
    Efficacy and Mechanism Evaluation, vol. 9, no. 4, pp. 1-153
    Contributions to Journals: Articles

  • Non-invasive testing for early detection of neovascular macular degeneration in unaffected second eyes of older adults: EDNA diagnostic accuracy study

    Banister, K., Cook, J. A., Scotland, G., Azuara-Blanco, A., Goulao, B., Heimann, H., Hernández, R. A., Hogg, R. E., Kennedy, C., Sivaprasad, S., Ramsay, C., Chakravarthy, U., EDNA study group
    Health Technology Assessment, vol. 26, no. 8
    Contributions to Journals: Articles

  • Axicabtagene ciloleucel for treating relapsed or refractory low-grade non-Hodgkin lymphoma

    Vadiveloo, T., Scotland, G., Booth, C., Robertson, C., Cruickshank, M., Aucott, L., Kennedy, C., Manson, P., Preston, G., Scotland, G., Brazzelli, M.
    Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence
    Books and Reports: Commissioned Reports

  • A multicentre open label randomised clinical trial using exhaled nitric oxide in addition to standard care to reduce asthma attacks in children

    Turner, S., Cotton, S., Wood, J., Bell, V., Raja, E. A., Scott, N., Morgan, H., Lawrie, L., Emele, D., Kennedy, C., Scotland, G., Fielding, S., MacLennan, G., Norrie, J., Forrest, M., Gaillard, E. A., Gaillard, E. A., de Jongeste, J., Pijnenburg, M. W., Thomas, M., Price, D.
    Efficacy and Mechanism Evaluation
    Contributions to Journals: Articles

  • Secukinumab for treating plaque psoriasis in children and young people

    Imamura, M., Kennedy, C., Aucott, L., Boyers, D., Cruickshank, M., Cooper, D., Manson, P., Ormerod, A., Brazzelli, M.
    Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence
    Books and Reports: Commissioned Reports

  • Teduglutide for treating short bowel syndrome

    Kennedy, C., Robertson, C., Cruickshank, M., Ayansina, D., Manson, P., Moroni, F., Brazzelli, M., Scotland, G.
    Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence
    Books and Reports: Commissioned Reports

  • Venetoclax with a hypomethylating agent or low dose cytarabine for untreated acute myeloid leukaemia unsuitable for intensive chemotherapy

    Cruickshank, M., Kennedy, C., Aucott, L., Booth, C., Imamura, M., Vadiveloo, T., Manson, P., Preston, G., Scotland, G., Brazzelli, M.
    Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence
    Books and Reports: Commissioned Reports

  • Darolutamide with androgen deprivation therapy for treating non-metastatic hormone-relapsed prostate cancer

    Scotland, G., Kennedy, C., Imamura, M., Cooper, D., Robertson, C., Booth, C., Urquhart, G., Brazzelli, M.
    Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence
    Books and Reports: Commissioned Reports

Refine

Books and Reports

Contributions to Journals

Update